Proven separately. Proven together.
For electrophysiologists considering concomitant for AFib patients who are independently indicated for both ablation and LAAC, the FARAWATCH™ approach brings together FARAPULSE™ PFA and WATCHMAN FLX™ Pro LAAC in one coordinated case resulting in one patient recovery period.
FARAWATCH is not a device; it’s a coordinated approach to AFib treatment for the right patients. Built on the combined experience of two category-leading Boston Scientific technologies and backed by growing real-world concomitant evidence, FARAWATCH enables one coordinated case from access and visualization to ablation and closure, with proven patient-centered outcomes.
Why concomitant FARAPULSE PFA and WATCHMAN LAAC?
- Streamlined approach that benefits patients, increases operational efficiency, and reduces resource burden.
- Patients and physicians can feel confident they are addressing both the symptoms of AFib while reducing the risk of stroke and bleeding at the same time.
- The most widely used technologies in PFA and LAAC, the FARAPULSE Platform and the WATCHMAN FLX Pro LAAC Device lead the way in enabling safe and efficient AFib treatment and stroke protection.
- From proven separately to proven together, ALIGN-AF, our dedicated concomitant evidence proves a strong safety profile and high LAA closure when using FARAPULSE and WATCHMAN together.
600,000+ WATCHMAN patients have been treated globally.
Clinically Proven
Real-world results demonstrated a strong safety profile and high LAA closure, supporting FARAWATCH — a concomitant FARAWAVE PFA and WATCHMAN FLX Pro procedure, as a practical approach for AFib patients eligible for both therapies.
Peer Perspectives: Case Insights
Clinicians highlight workflow best practices, clinical evidence, and patient benefit of combining FARAPULSE PFA and WATCHMAN FLX Pro procedures in one streamlined case.
FARAWATCH Resources
Find the resources you need to support your practice, increase efficiencies, improve patient outcomes, and transform a concomitant procedure into a more complete model of AFib care.